SATO PHARMACEUTICAL CO.,LTD.【JP:E00954】Cash flow
Market cap
P/E ratio
| 2014/07 | 2015/07 | 2016/07 | 2017/07 | 2018/07 | 2019/07 | 2020/07 | 2021/07 | 2022/07 | 2023/07 | |
| Depreciation & amortization | 1,472 | 1,565 | 1,553 | 1,831 | 1,700 | 1,535 | 1,509 | 1,523 | 1,765 | 1,641 |
| Cash from operations | 3,291 | 3,269 | 704 | 3,227 | 4,330 | 2,363 | 1,458 | 1,350 | 3,862 | 4,840 |
| Capital expenditures | -775 | -1,099 | -1,795 | -1,902 | -1,260 | -1,074 | -1,375 | -1,498 | -1,760 | -628 |
| Cash from investing | -1,870 | -2,297 | -1,374 | -7,878 | -934 | 243 | -1,260 | 342 | -3,357 | -3,752 |
| Payments for dividends | -100 | -100 | -150 | -99 | -99 | -99 | -98 | -98 | -98 | -98 |
| Repurchases of common stock | -89 | -104 | -158 | -117 | -119 | -144 | -39 | -15 | -52 | -61 |
| Cash from financing | -506 | -609 | -714 | -641 | -638 | -656 | -566 | -547 | -571 | -524 |